IBDEI1OG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26809,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,26809,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,26810,0)
 ;;=F32.1^^110^1287^18
 ;;^UTILITY(U,$J,358.3,26810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26810,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,26810,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,26810,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,26811,0)
 ;;=F32.2^^110^1287^19
 ;;^UTILITY(U,$J,358.3,26811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26811,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,26811,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,26811,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,26812,0)
 ;;=F32.3^^110^1287^14
 ;;^UTILITY(U,$J,358.3,26812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26812,1,3,0)
 ;;=3^MDD,Single Episode w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,26812,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,26812,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,26813,0)
 ;;=F32.4^^110^1287^16
 ;;^UTILITY(U,$J,358.3,26813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26813,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,26813,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,26813,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,26814,0)
 ;;=F32.5^^110^1287^15
 ;;^UTILITY(U,$J,358.3,26814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26814,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,26814,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,26814,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,26815,0)
 ;;=F33.9^^110^1287^13
 ;;^UTILITY(U,$J,358.3,26815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26815,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,26815,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,26815,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,26816,0)
 ;;=F33.0^^110^1287^10
 ;;^UTILITY(U,$J,358.3,26816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26816,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,26816,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,26816,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,26817,0)
 ;;=F33.1^^110^1287^11
 ;;^UTILITY(U,$J,358.3,26817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26817,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,26817,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,26817,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,26818,0)
 ;;=F33.2^^110^1287^12
 ;;^UTILITY(U,$J,358.3,26818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26818,1,3,0)
 ;;=3^MDD,Recurrent Episode,Severe
 ;;^UTILITY(U,$J,358.3,26818,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,26818,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,26819,0)
 ;;=F33.3^^110^1287^7
 ;;^UTILITY(U,$J,358.3,26819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26819,1,3,0)
 ;;=3^MDD,Recurrent Episode w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,26819,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,26819,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,26820,0)
 ;;=F33.41^^110^1287^9
 ;;^UTILITY(U,$J,358.3,26820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26820,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,26820,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,26820,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,26821,0)
 ;;=F33.42^^110^1287^8
 ;;^UTILITY(U,$J,358.3,26821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26821,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,26821,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,26821,2)
 ;;=^5003535
